Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators.
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.
Cornell is creating unique opportunities for innovation in the rapidly evolving field of structural biology thanks to cutting-edge facilities and support for intercampus collaborations between Cornell's Ithaca campus and Weill Cornell Medicine.
Small proteins that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study.
Cole, M.D. ’94, is the assistant vice provost for information services and chief information officer at Weill Cornell Medicine. He will begin his new role Jan. 1, 2023.
From new approaches for tendon injury treatment to biomass-based construction materials, Cornell Engineering’s inaugural Sprout Awards are funding unique research projects with the potential to grow partnerships across Cornell.
A $20 million gift from Andrew H. ’71 and Ann R. Tisch will foster engagement and collaboration between Cornell Tech and Weill Cornell Medicine, catalyzing new discoveries at the intersection of health and technology.
380 graduates in the Class of 2023 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall on May 18.
Ariel Avgar is an associate professor at Cornell University’s School of Industrial and Labor Relations and associate director with the Scheinman Institute on Conflict Resolution.
